Susquehanna International Group’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-149,408
| Closed | -$837 | – | 14010 |
|
|
2025
Q1 | $837 | Buy |
149,408
+11,213
| +8% | +$102 | ﹤0.01% | 12327 |
|
|
2024
Q4 | $1.37K | Buy |
+138,195
| New | +$2.75K | ﹤0.01% | 12040 |
|
|
2023
Q4 | – | Sell |
-21,272
| Closed | -$2.13K | – | 13467 |
|
|
2023
Q3 | $2.13K | Buy |
+21,272
| New | +$2.57K | ﹤0.01% | 11840 |
|
|
2023
Q2 | – | Sell |
-67,868
| Closed | -$8.14K | – | 13349 |
|
|
2023
Q1 | $8.14K | Buy |
+67,868
| New | +$13.4K | ﹤0.01% | 12234 |
|
|
2022
Q2 | – | Sell |
-12,765
| Closed | -$10K | – | 14146 |
|
|
2022
Q1 | $10K | Buy |
+12,765
| New | +$13.1K | ﹤0.01% | 12751 |
|
|
2021
Q3 | – | Sell |
-10,875
| Closed | -$52K | – | 13736 |
|
|
2021
Q2 | $52K | Buy |
+10,875
| New | +$40.4K | ﹤0.01% | 12292 |
|
|
2020
Q3 | – | Sell |
-18,612
| Closed | -$19K | – | 11267 |
|
|
2020
Q2 | $19K | Buy |
+18,612
| New | +$20.5K | ﹤0.01% | 9929 |
|
|
2020
Q1 | – | Sell |
-23,195
| Closed | -$9K | – | 11029 |
|
|
2019
Q4 | $9K | Sell |
23,195
-86,353
| -79% | -$27.1K | ﹤0.01% | 9558 |
|
|
2019
Q3 | $35K | Sell |
109,548
-41,050
| -27% | -$14K | ﹤0.01% | 9865 |
|
|
2019
Q2 | $63K | Sell |
150,598
-5,431
| -3% | -$2.17K | ﹤0.01% | 9784 |
|
|
2019
Q1 | $61K | Sell |
156,029
-29,188
| -16% | -$10.3K | ﹤0.01% | 8424 |
|
|
2018
Q4 | $59K | Buy |
+185,217
| New | +$62.1K | ﹤0.01% | 8426 |
|
Susquehanna International Group's PAVMZ Position: Q2 2025 in Review
Susquehanna International Group sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q2 2025, closing a stake of 149,408 shares — an estimated $837 sold.
Susquehanna International Group first reported a position in PAVMZ in Q4 2018 and held it in 12 quarters. The position peaked at $63K in Q2 2019. 0 funds tracked by Wall St. Rank hold PAVMZ as of Q2 2025.
- Susquehanna International Group reported no remaining PAVmed Inc. Series Z Warrant position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 149,408 PAVmed Inc. Series Z Warrant shares in Q2 2025, an estimated $837.
- Susquehanna International Group first reported a position in PAVmed Inc. Series Z Warrant in Q4 2018 and held it in 12 quarters.
- Susquehanna International Group's PAVmed Inc. Series Z Warrant position peaked at $63K in Q2 2019.
- 0 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.